• Profile
Close

A whey/guar “preload” improves postprandial glycaemia and glycated haemoglobin levels in type 2 diabetes: A 12-week, single-blind, randomized, placebo-controlled trial

Diabetes, Obesity and Metabolism Apr 04, 2019

Watson LE, et al. - In people with type 2 diabetes (T2DM), researchers assessed the impacts of 12 weeks of treatment with a whey/guar preload on gastric emptying, postprandial glycaemia and glycated haemoglobin (HbA1c) levels. A total of 79 people with T2DM treated with diet or metformin (HbA1c 49 ± 0.7 mmol/mol [6.6 ± 0.1%]) were randomized to receive 150 mL of flavoured preloads, containing either 17 g whey protein plus 5 g guar (n = 37) or flavoured placebo (n = 42), 15 minutes before two meals, for 12 weeks each day. In patients with well-controlled T2DM, 12-week treatment with low-dose whey/guar preload, taken twice a day before meals, had sustained effects of slowing down gastric emptying and decreasing postprandial blood glucose, which was related to a modest decrease in HbA1c without weight gain.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay